All terms in MeSH

Label Id Description
Tension-Type Headache C10.228.140.546.399.875
Ciona D000077262 [A genus of SEA SQUIRTS in the family Cionidae. ]
Sleepiness D000077260 [Compelling urge to sleep. ]
Carvedilol D000077261 [A carbazole and propanol derivative that acts as a non-cardioselective beta blocker and vasodilator. It has blocking activity for ALPHA 1 ADRENERGIC RECEPTORS and, at higher doses, may function as a blocker of CALCIUM CHANNELS; it also has antioxidant properties. Carvedilol is used in the treatment of HYPERTENSION; ANGINA PECTORIS; and HEART FAILURE. It can also reduce the risk of death following MYOCARDIAL INFARCTION. ]
Adenocarcinoma, Bronchiolo-Alveolar C04.588.894.797.520.055.500
Moxifloxacin D000077266 [A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent. ]
Fulvestrant D000077267 [An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer. ]
Calcium-Regulating Hormones and Agents D000077264 [Hormones and molecules with calcium-regulating hormone-like actions that modulate OSTEOLYSIS and other extra-skeletal activities to maintain calcium homeostasis. ]
Donepezil D000077265 [An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE. ]
Brimonidine Tartrate, Timolol Maleate Drug Combination D03.633.100.857.070.500
Brimonidine Tartrate D03.633.100.857.070
Pamidronate D000077268 [An aminobisphosphonate that inhibits BONE RESORPTION and is used for the treatment of osteolytic lesions, bone pain, and severe HYPERCALCEMIA associated with malignancies. ]
Petroleum Pollution N06.850.460.660
Andersen Syndrome C23.550.073.547.070
Long QT Syndrome C23.550.073.547
Lenalidomide D000077269 [A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. ]
Carcinoma, Renal Cell C13.351.937.820.535.160
Organic Cation Transport Proteins D12.776.543.585.450.250.812
Calcium Channels, R-Type D12.776.543.550.450.150.585.867
Pneumonia, Bacterial C01.748.610.540